Clinical Trials · NCT01913834

Nasally and sc Administered Teriparatide in Healthy Volunteers

Phase
Phase 1
Recruitment status
Unknown
Sponsor
Nottingham University Hospitals NHS Trust
Enrollment
7
Start date
Sep 2013
Locations
1 site, United Kingdom
Primary endpoint
Area under the plasma concentration time curve (AUC) of teriparatide for six hours after each single administration.
View Teriparatide compound reference